curasan AG is a Germany-based
company that specializes in the production and distribution of drugs
medical products. The Company operates in such fields as dental
bone and tissue regeneration, tissue engineering, and wound healing for
dental, spinal and orthopedic applications. cursan AG divides its
activities into the two segments: Pharmaceuticals and Biomaterials.
segment includes primarily the product Mitem, a drug for the treatment
of urinary bladder cancer. Biomaterials segment’s portfolio comprises
gelatine sponge for the control and wound healing; Curavisc, which is
for the treatment of joint arthrosis; Cerasorb, a synthetic bone
and regeneration material; Osbone, a spongious bone substitute, and
which supports tissue regeneration. In the dental field, Cerasorb is
by Riemser Arzneimittel AG.